Ares Allergy Holdings Plc announced appointment of Fereydoun Firouz its Chairman and Chief Executive Officer at its meeting held on July 21, 2015. Fereydoun Firouz joins Ares Allergy from Gurnet Point Capital LLC, where he was a Managing Partner.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+16.41% | 79.16B | |
+8.35% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Ares Allergy Holdings Plc Appoints Fereydoun Firouz as Chairman and CEO